Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
In clinical trials, many participants with type 2 diabetes achieved excellent glucose control on Retatrutide alone
Who Should Consider GLP-1 Therapy and the Role of Genetic Context GLP-1 therapy applies to adults with BMI 30 kg/m or 27 with weight-related conditions, or those with type 2 diabetes
44.4% (n=63) of patients had a documented Hurley stage at the initial visit, of which 57.1% (n=36) had stage II-III disease
There were no other apparent differences across the subgroup categories regarding the proportions of subjects achieving weight-loss responses (figure 2G,H)
What approval requires: Completion of Phase 3 clinical trials demonstrating safety and efficacy, submission of a New Drug Application (NDA) to the FDA, review and approval process that typically takes 6-12 months after submission
Menopause hormone therapy: A review of cardiovascular disease risk and benefits
